34 Teachers and Schools Across North America Receive $10,000 Amgen Award

AmgenAmgen (Nasdaq: AMGN) announced the 34 science teachers in the United States (U.S.), Canada and Puerto Rico who are this year's recipients of the 18th annual Amgen Award for Science Teaching Excellence. The award recognizes extraordinary teachers in grades K-12 whose dedication to students has had a significant impact on the learning and interest of the future generation of scientists.

Since the program's inception in 1992, Amgen has awarded more than $2.5 million to educators who have made exceptional science-teaching contributions and who have achieved demonstrated results in student learning in communities where Amgen operates. In 2010, Amgen received nearly 250 applications for the Amgen Award for Science Teaching Excellence and winners were honored at special ceremonies in their respective Amgen communities or during surprise presentations at their schools.

"Amgen believes in the enduring value of science education and is committed to supporting programs that encourage bright young minds to explore a future in science," said Joe Miletich, senior vice president of research and development at Amgen. "We applaud this year's award recipients for their dedication to delivering quality science education to tomorrow's innovators."

The 34 selected winners will receive the following benefits:

  • An unrestricted cash award of $5,000 USD or $5,000 CAD; and
  • A restricted $5,000 USD or $5,000 CAD cash grant to the recipient's school for the expansion or enhancement of a school science program, science resources, or the professional development of the school's science teachers;

Along with the award applications, teachers were asked to submit an innovative science lesson plan which had been successfully introduced in their classroom. Amgen will post select winning lesson plans to its Web site to promote the sharing of this knowledge with educators across the country to bolster excellence and innovation in science teaching.

Amgen partnered with the University of Wisconsin - Madison School of Education to judge the teaching awards in the U.S. and Puerto Rico. The School's Department of Curriculum and Instruction is consistently recognized as a leader in education, and their expertise aided in the selection of the strongest possible winners.

Nominations are solicited every fall with winners selected based on the following criteria: innovative science lesson plan, creativity and effectiveness of teaching methods; and the plan for the use of grant money to improve science education resources in their schools.

For more information about this year's winners and the program, please visit http://www.amgen.com/citizenship/aaste.html.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Most Popular Now

Delivering insulin in a pill

Given the choice of taking a pill or injecting oneself with a needle, most of us would opt to regulate a chronic health condition by swallowing a pill. But for millions o...

Probiotics can protect the skeletons of older wome…

For the first time in the world, researchers at the University of Gothenburg, Sweden, have demonstrated that probiotics, dietary supplements with health-promoting bacteri...

Alzheimer's breakthrough: Brain metals that may dr…

Alzheimer's disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegen...

FDA approves first drug comprised of an active ing…

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms o...

Can aspirin treat Alzheimer's?

A regimen of low-dose aspirin potentially may reduce plaques in the brain, which will reduce Alzheimer's disease pathology and protect memory, according to neurological r...

In mice, stem cells seem to work in fighting obesi…

Obesity is an increasing global health problem associated with several comorbidities and a high risk of mortality. A wide spectrum of interventions has been proposed for ...

FDA takes steps to foster greater efficiency in bi…

Today, the agency withdrew the draft guidance, "Statistical Approaches to Evaluate Analytical Similarity," issued in September 2017. The draft guidance, if finalized as w...

Research shows how a moderate dose of alcohol prot…

For at least 20 years, research has shown that for many people, moderate consumption of alcohol can protect the heart, but the reason for this is poorly understood. A stu...

'Kiss of death' cancer

It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negativ...

Some existing anti-cancer drugs may act in part by…

Bolstering the notion that RNA should be considered an important drug-discovery target, scientists at Scripps Research have found that several existing, FDA-approved anti...

Novartis Clear about Psoriasis survey data highlig…

Novartis announced today the publication of global Clear about Psoriasis survey data in the Journal of the European Academy of Dermatology and Venereology[1]. The publica...

Poliovirus therapy for recurrent glioblastoma has …

A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, wit...